Concepts (79)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lupus Erythematosus, Systemic | 6 | 2024 | 169 | 4.370 |
Why?
|
| Early Detection of Cancer | 2 | 2024 | 326 | 1.380 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2024 | 230 | 1.370 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2023 | 252 | 0.900 |
Why?
|
| Vaginal Smears | 1 | 2021 | 52 | 0.760 |
Why?
|
| Scleroderma, Systemic | 1 | 2022 | 116 | 0.750 |
Why?
|
| Patient Compliance | 1 | 2024 | 463 | 0.730 |
Why?
|
| Palliative Care | 4 | 2017 | 424 | 0.670 |
Why?
|
| Hypertension, Pulmonary | 1 | 2023 | 422 | 0.620 |
Why?
|
| Terminal Care | 4 | 2016 | 113 | 0.590 |
Why?
|
| Reminder Systems | 1 | 2016 | 60 | 0.520 |
Why?
|
| Death, Sudden | 1 | 2014 | 46 | 0.480 |
Why?
|
| Vital Signs | 1 | 2014 | 18 | 0.470 |
Why?
|
| Malnutrition | 1 | 2017 | 195 | 0.460 |
Why?
|
| Terminally Ill | 1 | 2014 | 28 | 0.460 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2022 | 1168 | 0.450 |
Why?
|
| Neoplasms | 5 | 2017 | 2743 | 0.450 |
Why?
|
| Mortality | 1 | 2014 | 221 | 0.430 |
Why?
|
| Physical Examination | 1 | 2014 | 162 | 0.430 |
Why?
|
| Medication Adherence | 1 | 2016 | 383 | 0.400 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 2476 | 0.360 |
Why?
|
| Critical Care | 1 | 2014 | 644 | 0.320 |
Why?
|
| Immunosuppressive Agents | 2 | 2023 | 645 | 0.320 |
Why?
|
| Cross-Sectional Studies | 3 | 2024 | 3267 | 0.270 |
Why?
|
| Humans | 17 | 2024 | 121122 | 0.270 |
Why?
|
| Incidence | 3 | 2022 | 2969 | 0.260 |
Why?
|
| Aged | 7 | 2024 | 18432 | 0.260 |
Why?
|
| Prospective Studies | 4 | 2022 | 5858 | 0.260 |
Why?
|
| Adult | 7 | 2024 | 28389 | 0.240 |
Why?
|
| Middle Aged | 7 | 2024 | 25297 | 0.230 |
Why?
|
| Heart Failure | 1 | 2017 | 2122 | 0.230 |
Why?
|
| Rheumatic Diseases | 1 | 2024 | 65 | 0.220 |
Why?
|
| Longitudinal Studies | 3 | 2023 | 1264 | 0.220 |
Why?
|
| Observational Studies as Topic | 1 | 2023 | 78 | 0.210 |
Why?
|
| Blood Sedimentation | 1 | 2022 | 28 | 0.210 |
Why?
|
| Rheumatology | 1 | 2023 | 105 | 0.200 |
Why?
|
| Female | 9 | 2024 | 64043 | 0.200 |
Why?
|
| Consensus | 2 | 2023 | 602 | 0.200 |
Why?
|
| Retrospective Studies | 3 | 2023 | 15593 | 0.180 |
Why?
|
| Cyclophosphamide | 1 | 2022 | 422 | 0.170 |
Why?
|
| Analgesics, Opioid | 1 | 2024 | 394 | 0.170 |
Why?
|
| Young Adult | 4 | 2024 | 8645 | 0.170 |
Why?
|
| C-Reactive Protein | 1 | 2022 | 404 | 0.170 |
Why?
|
| Medicare | 1 | 2022 | 417 | 0.160 |
Why?
|
| Proportional Hazards Models | 1 | 2022 | 1284 | 0.160 |
Why?
|
| Patient-Centered Care | 1 | 2021 | 222 | 0.160 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2024 | 708 | 0.150 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2024 | 807 | 0.150 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 1024 | 0.150 |
Why?
|
| Off-Label Use | 1 | 2017 | 24 | 0.140 |
Why?
|
| Risk Factors | 2 | 2022 | 9617 | 0.120 |
Why?
|
| Antirheumatic Agents | 1 | 2016 | 115 | 0.120 |
Why?
|
| Survival | 1 | 2014 | 19 | 0.120 |
Why?
|
| Self Report | 1 | 2016 | 485 | 0.110 |
Why?
|
| Biomarkers | 1 | 2022 | 2917 | 0.110 |
Why?
|
| Sex Factors | 1 | 2016 | 1220 | 0.100 |
Why?
|
| Referral and Consultation | 1 | 2016 | 522 | 0.100 |
Why?
|
| Cohort Studies | 1 | 2021 | 4603 | 0.100 |
Why?
|
| Hospitalization | 2 | 2017 | 1717 | 0.100 |
Why?
|
| United States | 2 | 2024 | 10347 | 0.090 |
Why?
|
| Critical Illness | 1 | 2014 | 587 | 0.090 |
Why?
|
| Age Factors | 1 | 2016 | 2759 | 0.090 |
Why?
|
| Survival Rate | 1 | 2014 | 1981 | 0.080 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 630 | 0.080 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 1998 | 0.080 |
Why?
|
| Male | 5 | 2024 | 58941 | 0.080 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 2787 | 0.070 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 6095 | 0.070 |
Why?
|
| Texas | 1 | 2014 | 3515 | 0.070 |
Why?
|
| Tertiary Care Centers | 2 | 2017 | 227 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2014 | 3203 | 0.060 |
Why?
|
| Health Care Surveys | 1 | 2024 | 280 | 0.050 |
Why?
|
| Drug Prescriptions | 1 | 2024 | 213 | 0.050 |
Why?
|
| Adolescent | 2 | 2024 | 18761 | 0.050 |
Why?
|
| Autoimmune Diseases | 1 | 2024 | 250 | 0.050 |
Why?
|
| Cancer Care Facilities | 1 | 2017 | 29 | 0.040 |
Why?
|
| Outpatients | 1 | 2016 | 253 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2017 | 1454 | 0.030 |
Why?
|
| Prognosis | 1 | 2016 | 4473 | 0.020 |
Why?
|